Clinicopathological features of pregnancy-associated breast cancer at Chris Hani Baragwanath Academic Hospital, South Africa
DOI:
https://doi.org/10.7196/SAMJ.2026.v116i6.4285Keywords:
Pregnancy-associated breast cancer, clinicopathological features, PrognosisAbstract
Background. Pregnancy-associated breast cancer (PABC), defined as cancer diagnosed during pregnancy or up to 1 year postpartum, tends to present with tumours displaying more adverse prognostic pathological features compared with those diagnosed outside of pregnancy. It is unclear if this is due to the more aggressive tumour biology associated with early-onset breast cancer, or influenced by the pregnancy independently.
Objectives. To compare the clinicopathological features of patients presenting with PABC with their age-matched non-PABC controls.
Methods. Records of females of reproductive age diagnosed with breast cancer from 1 October 2006 to 31 October 2020 were retrospectively reviewed using the Chris Hani Baragwanath Academic Hospital Breast Unit electronic database. Cases of PABC were identified, and non‑PABC cases were selected as age-matched controls at a 2:1 ratio to each PABC case.
Results. A total of 1 056 patients were eligible for inclusion, with 63 meeting criteria for PABC. After excluding 10 cases, 53 PABC cases were age-matched to 106 controls. The incidence of PABC was 1.5%, with a median age of 36 years. Over 90% of patients presented with palpable breast masses. PABC patients presented with significantly larger tumours (5.5 cm v. 4.0 cm) and higher nuclear grades compared with age-matched controls. PABC patients also demonstrated more oestrogen (40% v. 23%) and progesterone receptor (47% v. 28%) negativity compared with controls.
Conclusion. PABC patients from our population presented with more adverse clinicopathological tumour characteristics than their age-matched controls. These findings align with existing literature, and would likely contribute to a worse prognosis in this patient group
References
1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of
incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 2018;68(6):394-424.
https://acsjournals.onlinelibrary.wiley.com (accessed 10 August 2023).
2. World Health Organization. The Global Cancer Observatory. South Africa. Globocan, 2018. https://
gco.iarc.who.int/media/globocan/factsheets/populations/710-south-africa-fact-sheet.pdf (accessed 10
August 2023).
3. Amant F, Deckers S, Van Calsteren K, et al. Breast cancer in pregnancy: Recommendations of an
international consensus meeting. Eur J Cancer 2010;46(18):3158-3168. https://doi.org/10.1016/j.
ejca.2010.09.010
4. Basaran D, Turgal M, Beksac K, Ozyuncu O, Aran O, Beksac MS. Pregnancy-associated breast cancer:
Clinicopathological characteristics of 20 cases with a focus on identifiable causes of diagnostic delay.
Breast Care 2014;9(5):355-359. https://doi.org/10.1159/000366436
5. Wang B, Yang Y, Jiang Z, et al. Clinicopathological characteristics, diagnosis, and prognosis of pregnancyassociated
breast cancer. Thorac Cancer 2019;10(5):1060-1068. https://doi.org/10.1111/1759-7714.13045
6. Woo JC, Yu T, Hurd T. Breast cancer in pregnancy: A literature review. Arch Surg 2003;138(1):91.
https://doi.org/10.1001/archsurg.138.1.91
7. Pena-Enriquez R, Bermejo B, Pollan M, et al. Molecular characterisation of pregnancy-associated
breast cancer and insights on timing from GEICAM-EMBARCAM study. NPJ Breast Cancer
2025;8:11(1):12. https://doi.org/10.1038/s41523-025-00718-x
8. Botha MH, Rajaram S, Karunaratne K. Cancer in pregnancy. Int J Gynecol Obstet 2018;143(S2):137‑142.
https://doi.org/10.1002/ijgo.12621
9. Akhlaqi M, Ghofrani A, Najdi N, et al. A systematic review and meta-analysis of pregnancy-associated
breast cancer incidence rate. BMC Cancer 2025;25(1):660. https://doi.org/10.1186/s12885-025-14091-2
10. Al-Awadhi A, Al-Shamsi S, Hourani M, et al. Clinicopathological features and prognosis for
pregnancy-associated breast cancer: A matched case-control study. J Clin Oncol 2024;42(16):e12573.
https://doi.org/10.1200/JCO.2024.42.16_suppl.e12573
11. Dusengimana JMV, Hategekimana V, Borg R, et al. Pregnancy-associated breast cancer in rural
Rwanda: The experience of the Butaro Cancer Center of Excellence. BMC Cancer 2018;18(1):634.
https://doi.org/10.1186/s12885-018-4535-y
12. Hou N, Ogundiran T, Ojengbede O, et al. Risk factors for pregnancy-associated breast cancer: A report
from the Nigerian Breast Cancer Study. Ann Epidemiol 2013;23(9):551-557. https://doi.org/10.1016/j.
annepidem.2013.06.0
13. Yu HH, Cheung PS, Leung RC, Leung T, Kwan W. Current management of pregnancy-associated
breast cancer. Hong Kong Med J 2017;23(4):387-394. https://doi.org/10.12809/hkmj166049
14. Azim HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA. Prognosis of
pregnancy-associated breast cancer: A meta-analysis of 30 studies. Cancer Treat Rev 2012;38(7):834‑842.
https://doi.org/10.1016/j.ctrv.2012.06.004
15. Navrozoglou I, Vrekoussis T, Kontostolis E, et al. Breast cancer during pregnancy: A mini- review. Eur
J Surg Oncol 2008;34(8):837-843. https://doi.org/10.1016/j.ejso.2008.01.029
16. Ruiz R, Herrero C, Strasser-Weippl K, et al. Epidemiology and pathophysiology of pregnancy-associated
breast cancer: A review. Breast 2017;35(3):136-141. https://doi.org/10.1016/j.breast.2017.07.008
17. Durrani S, Akbar S, Heena H. Breast cancer during pregnancy. Cureus 2018;10(7):e2941 https://doi.
org/10.7759/cureus.2941
18. Martínez MT, Bermejo B, Hernando C, Gambardella V, Cejalvo JM, Lluch A. Breast cancer in pregnant
patients: A review of the literature. Eur J Obstet Gynecol Reprod Biol 2018;230(1):222-227. https://doi.
org/10.1016/j.ejogrb.2018.04.029
19. Donker A, Lathlean J, Wiafe S, et al. Factors contributing to late presentation of breast cancer in Africa:
A systematic literature review. Arch Med 2015;8(2):2. https://doi.org/10.1200/JGO.19.00402
20. Kordy N, Haggag A, Seddik S, Eid R, Shash E. 302P clinicopathological features and outcomes of
pregnancy associated breast cancer: Case control study – single institution experience. Ann Oncol
2023;34(S2):S304. https://doi.org/10.1016/j.annonc.2023.09.498
21. Johansson ALV, Andersson TM-L, Hsieh C, et al. Tumour characteristics and prognosis in
women with pregnancy-associated breast cancer. Int J Cancer 2018;142(7):1343-1354. https://doi.
org/10.1002/ijc.31174
22. Hartman EK, Eslick GD. The prognosis of women diagnosed with breast cancer before, during
and after pregnancy: A meta-analysis. Breast Cancer Res Treat 2016;160(2):347-360. https://doi.
org/10.1007/s10549-016-3989-3
23. Korbi A, Felfoul A, Farhat IB, et al. Retrospective study of 35 cases of breast cancer associated with
pregnancy at the Monastir Maternity and Neonatology Center. Pan Afr Med J 2025;52(45):45887.
https://doi.org/10.11604/pamj.2025.52.45.45887
24. O’Sullivan CC, Irshad S, Wang Z, et al. Clinico-pathologic features, treatment and outcomes of breast
cancer during pregnancy or the post-partum period. Breast Cancer Res Treat 2020;180(3):695-706.
https://doi.org/10.1007/s10549-020-05585-7
25. Amant F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed
during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31(20):2532-2539.
https://doi.org/10.1200/JCO.2012.45.6335
26. Government of South Africa. People of South Africa. Pretoria: SA Government, 2022. https://www.gov.
za/about-sa/south-africas-people (accessed 12 February 2025).
27. Parliament of the Republic of South Africa. Overview of Chris Hani Baragwanath Academic Hospital.
Pretoria: SA Parliament, 2022. https://www.parliament.gov.za/storage/app/media/Pages/2022/3-
march/22-03-2022_National_Council_of_Provinces_Provincial_Week/Gauteng/Chris_Hani_
Baragwanath_Academic_Hospital_Site_Profile.pdf (accessed 7 June 2024).
28. Loibl S, Andre HN, Bachelot T, et al. Early breast cancer: ESMO Clinical Practice Guideline for
diagnosis, treatment and follow-up. European Society for Medical Oncology, 2023. https://www.esmo.
org/guidelines/guidelines-by-topic/esmo-clinical-practice-guidelines-breast-cancer/early-breastcancer
(accessed 10 August 2023).
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 L Levenberg, D Kruger, H Cubash, N Murugan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
